These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. Alvarez B; Ruiz C; Chacón P; Alvarez-Sabin J; Matas M J Vasc Surg; 2004 Sep; 40(3):469-75. PubMed ID: 15337875 [TBL] [Abstract][Full Text] [Related]
24. Carotid atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies. Milei J; Parodi JC; Fernandez Alonso G; Barone A; Beigelman R; Ferreira LM; Arrigoni G; Matturri L Cardiologia; 1996 Jun; 41(6):535-42. PubMed ID: 8766416 [TBL] [Abstract][Full Text] [Related]
25. NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis. Eilenberg W; Stojkovic S; Kaider A; Kozakowski N; Domenig CM; Burghuber C; Nanobachvili J; Huber K; Klinger M; Neumayer C; Huk I; Wojta J; Demyanets S Clin Chem Lab Med; 2017 Nov; 56(1):147-156. PubMed ID: 28672747 [TBL] [Abstract][Full Text] [Related]
26. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Horne BD; Camp NJ; Carlquist JF; Muhlestein JB; Kolek MJ; Nicholas ZP; Anderson JL Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005 [TBL] [Abstract][Full Text] [Related]
27. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402 [TBL] [Abstract][Full Text] [Related]
28. Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome. Peeters W; Moll FL; Vink A; van der Spek PJ; de Kleijn DP; de Vries JP; Verheijen JH; Newby AC; Pasterkamp G Eur Heart J; 2011 Sep; 32(18):2314-25. PubMed ID: 21289041 [TBL] [Abstract][Full Text] [Related]
29. MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study. Volcik KA; Campbell S; Chambless LE; Coresh J; Folsom AR; Mosley TH; Ni H; Wagenknecht LE; Wasserman BA; Boerwinkle E Atherosclerosis; 2010 May; 210(1):188-93. PubMed ID: 20064641 [TBL] [Abstract][Full Text] [Related]
30. Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis. Abd-Allah SH; El-Shal AS; Shalaby SM; Pasha HF; Abou El-Saoud AM; Abdel Galil SM; Mahmoud TA IUBMB Life; 2015 Dec; 67(12):934-42. PubMed ID: 26510114 [TBL] [Abstract][Full Text] [Related]
32. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis. Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279 [TBL] [Abstract][Full Text] [Related]
33. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Pawlak K; Pawlak D; Mysliwiec M Atherosclerosis; 2007 Jan; 190(1):199-204. PubMed ID: 16510149 [TBL] [Abstract][Full Text] [Related]
34. MMP-10 rs17435959 Polymorphism is Associated with the Formation and Stability of Carotid Atherosclerosis Plaque: A Case-Control Study. Wu LN; Wang WF; Wang XW; Li WL; Luo S; Ni H; Zheng HB; Hong WJ; Jiang YQ; Zhu F J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106045. PubMed ID: 34418671 [TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms. Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799 [TBL] [Abstract][Full Text] [Related]
36. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. Okamoto K; Mimura K; Murawaki Y; Yuasa I J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221 [TBL] [Abstract][Full Text] [Related]
37. [Research on the relationship between levels of soluble cluster of differentiation 40 ligand, matrix metalloproteinase 9 and pregnancy-associated plasma protein A in serum and stability of carotid plaques]. Han YP; Wang DM; Liu JC; Wang LJ; Lu J; Qi P; Li SY; Liu BY Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):70-3. PubMed ID: 22490296 [TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population. Tang LJ; Chen XF; Zhu M; Jiang JJ; Lu XB; Du YX; Wang B; Fang CF; Xue YS; Shen WF Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894 [TBL] [Abstract][Full Text] [Related]
39. Association of MMP-9 gene polymorphisms with Behçet's disease risk. Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450 [TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. Söder PO; Meurman JH; Jogestrand T; Nowak J; Söder B J Periodontal Res; 2009 Aug; 44(4):452-8. PubMed ID: 18973519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]